C(-106)T polymorphism of the aldose reductase gene and the progression rate of diabetic retinopathy
dc.contributor.author | Olmos, Pablo | |
dc.contributor.author | Bastias, Maria Juliana | |
dc.contributor.author | Vollrath, Valeska | |
dc.contributor.author | Toro, Luis | |
dc.contributor.author | Trincado, Arturo | |
dc.contributor.author | Salinas, Pablo | |
dc.contributor.author | Claro, Juan Carlos | |
dc.contributor.author | Lopez, Jose Manuel | |
dc.contributor.author | Acosta, Ana Maria | |
dc.contributor.author | Miquel, Juan Francisco | |
dc.contributor.author | Castro, Juan | |
dc.date.accessioned | 2024-01-10T13:11:32Z | |
dc.date.available | 2024-01-10T13:11:32Z | |
dc.date.issued | 2006 | |
dc.description.abstract | Purpose: To study the C(-106)T polymorphism in the promoter of the aldose reductase (ALR2) gene: (a) its local prevalence and (b) its modulation of the susceptibility for developing retinopathy. | |
dc.description.abstract | Methods: DNAs of 96 control subjects and 53 long-standing (duration 17.9 +/- 5.4 years) type-2 diabetic patients were analyzed by PCR-RFLP with BfaI enzyme. Retinopathy was graded with 2-eye, 7-field fundus color photography. The IMF-HbA1c was the arithmetic mean of all HbA1c's of each patient. | |
dc.description.abstract | Results: The genotypes in the controls were CC = 57 (59.4%), CT = 32 (33.3%) and TT = 7 (7.3%), with Hardy-Weinberg chi(2) = 0.793 (p > 0.50). Among 53 diabetics, CC = 24 (45.3%), CT = 26 (49.0%) and TT = 3 (5.7%). The correlation between IMF-HbA1c and retinopathy progression rate was significant on CC (r = 0.6102, p = 0.0072) but not in CT + TT genotypes (r = 0.26, p = 0.1811). | |
dc.description.abstract | Conclusions: In Chilean adults, the frequency of the C(-106)T polymorphism of the ALR2 gene was similar to that reported by others. Type-2 diabetics with the CC genotype were more susceptible for developing retinopathy as a result of chronic hyperglycemia than those with the CT or TT genotype. (c) 2006 Elsevier Ireland Ltd. All rights reserved. | |
dc.fechaingreso.objetodigital | 2024-04-09 | |
dc.format.extent | 8 páginas | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1016/j.diabres.2006.03.019 | |
dc.identifier.issn | 0168-8227 | |
dc.identifier.pubmedid | MEDLINE:16701918 | |
dc.identifier.uri | https://doi.org/10.1016/j.diabres.2006.03.019 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/78058 | |
dc.identifier.wosid | WOS:000241649700010 | |
dc.information.autoruc | Medicina;Miquel J;S/I;72216 | |
dc.information.autoruc | Medicina;Olmos P;S/I;98949 | |
dc.issue.numero | 2 | |
dc.language.iso | en | |
dc.nota.acceso | contenido parcial | |
dc.pagina.final | 182 | |
dc.pagina.inicio | 175 | |
dc.publisher | ELSEVIER IRELAND LTD | |
dc.revista | DIABETES RESEARCH AND CLINICAL PRACTICE | |
dc.rights | acceso restringido | |
dc.subject | aldose reductase | |
dc.subject | polymorphism | |
dc.subject | diabetes | |
dc.subject | retinopathy | |
dc.subject | MICROVASCULAR COMPLICATIONS | |
dc.subject | JAPANESE PATIENTS | |
dc.subject | MELLITUS | |
dc.subject | SUSCEPTIBILITY | |
dc.subject | NEPHROPATHY | |
dc.subject | REGION | |
dc.subject | NIDDM | |
dc.subject | RISK | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | C(-106)T polymorphism of the aldose reductase gene and the progression rate of diabetic retinopathy | |
dc.type | artículo | |
dc.volumen | 74 | |
sipa.codpersvinculados | 72216 | |
sipa.codpersvinculados | 98949 | |
sipa.index | WOS | |
sipa.trazabilidad | Carga SIPA;09-01-2024 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- C(-106)T polymorphism of the aldose reductase gene and the progression rate of diabetic retinopathy.pdf
- Size:
- 3.03 KB
- Format:
- Adobe Portable Document Format
- Description: